1. Introduction
===============

*Antrodia camphorata* Wu, Ryvarden & Chang (Polyporaceae), a fungus indigenous to Taiwan, was used by the aborigine as a hepatinica and anti-alcoholic agent initially and has been gradually used as a folk remedy for the treatment of liver cancer and various cardiovascular diseases in the past few decades \[[@B1-molecules-19-21378]\]. The fermentation and development of this fungus have already become one of the major components of the biotechnology industry in Taiwan recently, and some of the chemical entities isolated from the fermented products, e.g., antroquinonol \[[@B2-molecules-19-21378]\] and ergosta-7,9,22*E*-trien-3β-ol \[[@B3-molecules-19-21378]\], were selected as leads for new drug development. Although over one hundred compounds have been identified from this fungus so far \[[@B4-molecules-19-21378],[@B5-molecules-19-21378],[@B6-molecules-19-21378]\], new chemical entities are still reported continually by virtue of varied culturing conditions for this fungus. In continuing our investigations on the chemical constituents of the mycelium of *Antrodia camphorata*, one new phenylmethanoid, 6-methoxy-4-methyl-2,3-(methylenedioxy)phenol (**1**), and one new stilbene, 4,4\'-(ethane-1,2-diyl)bis(2,3,6-trimethoxyphenol)(**2**), together with 2,3,6-trimethoxy-4-methylphenol (**3**), 1(10→6)*abeo*-ergosta-5,7,9,22-tetraen-3α-ol (**4**), citreoanthrasteroid B (**5**) and dankasterones A (**6**) and B (**7**) ([Figure 1](#molecules-19-21378-f001){ref-type="fig"}) were isolated and characterized on the basis of the spectral analysis. The paper describes the isolation and identification of compounds **1**--**7** from *A.* *camphorata* along with their anticancer effects in murine colorectal cancer CT26 cells and human leukemia K562 cells.

![Chemical structures of **1**--**7** isolated in this study.](molecules-19-21378-g001){#molecules-19-21378-f001}

2. Results and Discussion
=========================

From the methanolic extracts of the solid-state cultured, fermented dried powder of *A. camphorata,* seven major compounds, including one new phenylmethanoid, **1**, and one new stilbene, **2**, along with a known phenylmethanoid, **3**, and four steroids, **4**--**7**, were isolated by sequential separation on Si-gravity column and normal-phase HPLC. Compound **3** was obtained as an amorphous white solid whose ^1^H, ^13^C-NMR, IR, optical rotation and MS were consistent with those of synthetic 2,3,6-trimethoxy-4-methylphenol \[[@B7-molecules-19-21378]\], and this is the first time Compound **3** has been isolated from a natural resource. Compounds **4** and **5**, two rare 1(10→6)*abeo*-ergostane-type steroids, were identified as 1(10→6)*abeo*-ergosta-5,7,9,22-tetraen-3α-ol (**4**), obtained previously from the stromata of *Epichloe typhina* \[[@B8-molecules-19-21378]\], and citreoanthrasteroid B (**5**), isolated from a hybrid bacterial strain, KO 0231 \[[@B9-molecules-19-21378]\]. Compounds **6** and **7**, two uncommon 13(14→8)*abeo*-ergostane-type steroids, were characterized as respective dankasterones A and B, which were isolated previously from a *Halichondria* sponge-derived fungus, *Gymnascella dankaliensis* \[[@B10-molecules-19-21378]\].

Compound **1** was afforded as a colorless amorphous solid with the molecular formula of C~9~H~10~O~4~ as established through the analysis of its ^13^C-NMR and HRESIMS data. The IR absorption peaks of **1** at 3277, 1626 and 1527 cm^−1^ indicated that **1** contained a benzene moiety bearing a hydroxy functionality as reflected in its ^1^H- and ^13^C-NMR data. The ^1^H-NMR of **1** exhibited a phenyl proton at δ~H~ 6.27 (s, 1H), a benzene-borne methyl at δ~H~ 2.16 (s, 3H), a benzene-borne methoxyl at δ~H~ 3.82 (s, 3H) and a methylenedioxy group at δ~H~ 5.91 (s, 2H), which were further confirmed by their corresponding six phenyl resonances at δ~C~ 109.0 (d), 118.9 (s), 131.9 (s), 133.6 (s), 135.0 (s) and 136.8 (s), one methyl resonance at δ~C~ 15.8 (q), one methoxyl resonance at δ~C~ 57.2 (q) and one dioxygenated methylene resonance at δ~C~ 101.5 (t) in the ^13^C-NMR of **1**. Further analysis of the 2D NMR data of **1**, key cross-peaks of δ~H~ 2.16 (H~3~-7)/δ~C~ 109.0 (C-5), 118.9 (C-4) and 131.9 (C-3), δ~H~ 3.82 (OMe-6)/δ~C~ 136.8 (C-6), δ~H~ 5.91 (H~2~-8)/δ~C~ 131.9 (C-3) and 135.0 (C-2), δ~H~ 6.27 (H-5)/δ~C~ 133.6 (C-1) in the HMBC spectrum and mutual-correlated cross peaks of δ~H~ 6.27 (H-5)/δ~H~ 3.82 (OMe-6) and δ~H~ 2.16 (H~3~-7) in the NOESY spectrum ([Figure 2](#molecules-19-21378-f002){ref-type="fig"}) established the locations of all of the functional groups attached to the benzene ring. Thus, **1** was deduced as the shown phenylmethanoid and was named 6-methoxy-4-methyl-2,3-(methylenedioxy)phenol.

![Key HMBC and NOESY of **1**.](molecules-19-21378-g002){#molecules-19-21378-f002}

Compound **2**, obtained as a colorless amorphous solid, was a symmetrical chemical entity as judged from its molecular formula, C~20~H~26~O~8~, deduced from HRESIMS and only ten resonances in the ^13^C-NMR spectrum. The IR spectrum of **2** confirmed the presence of a hydroxyl group (3410 cm^−1^) and a benzene ring (1610 and 1503 cm^−1^). The ^13^C-NMR along with the DEPT of **2** displayed only ten signals (indeed, twenty signals due to symmetry), including one methylene carbon at δ~C~ 31.4, three benzene-borne methoxyl carbons at δ~C~ 56.4, 60.7 and 61.0 and six phenyl carbons at δ~C~ 107.2, 125.2, 137.3, 140.4, 143.2 and 145.2. The ^1^H-NMR spectrum showed signals for the methylene group at δ~H~ 2.78 (s, 2H), three methoxyl groups at δ~H~ 3.79 (s, 3H), 3.80 (s, 3H) and 3.91 (s, 3H), one hydroxyl group at δ~H~ 5.45 (brs, 1H) and one phenyl proton at δ~H~ 6.38 (s, 1H). The above assignments indicated that **2** had a stilbene skeleton with three methoxyl and one hydroxyl groups on each benzene ring. The locations of three methoxy, one hydroxy and one phenyl proton were further corroborated by key HMBC interpretations, including δ~H~ 2.78 (H-7, -7\')/δ~C~ 107.2 (C-5, -5\'), 125.2 (C-4, -4\') and 145.2 (C-3, -3\'), δ~H~ 3.79 (OMe-3, -3\')/δ~C~ 145.2 (C-3, -3\'), δ~H~ 3.80 (OMe-6, -6\')/δ~C~ 143.2 (C-6, -6\'), δ~H~ 3.91 (OMe-2, -2\')/δ~C~ 140.4 (C-2, -2\'), δ~H~ 5.45 (OH-1, -1\')/δ~C~ 137.3 (C-1, -1\'), 140.3 (C-2, -2\'), 143.2 (C-6, -6\') and δ~H~ 6.38 (H-5, -5\')/δ~C~ 137.3 (C-1, -1\') and 145.2 (C-3, -3\'), as well as key NOESY correlations, including δ~H~ 6.38 (H-5, -5\')/δ~H~ 2.78 (H-7, -7\') and 3.80 (OMe-6, -6\') and δ~H~ 3.79 (OMe-3, -3\')/δ~H~ 2.78 (H-7, -7\') and 3.91 (OMe-2, -2\') ([Figure 3](#molecules-19-21378-f003){ref-type="fig"}). Accordingly, **1** was determined as the shown dihydrostilbene and was named 4,4′-(ethane-1,2-diyl)bis(2,3,6-trimethoxyphenol). Compound **2** was speculated from the oxidative coupling between two molecules of Compound **3**.

For the anticancer activity, [Table 1](#molecules-19-21378-t001){ref-type="table"} shows the IC~50~ values of compounds **1**‒**7** against murine colorectal cancer CT26 cells and human leukemia K562 cells. Compounds **1**‒**3** exhibited no obvious effect toward CT26 and K562 cells with their IC~50~ values higher than 20 μM, and **4**--**7** showed significant cytotoxicity toward murine colorectal CT26 and human leukemia K562 cancer cell lines with IC~50~ values ranging from 6.7 to 18.2 μM and from 12.5 to 23.1 μM, respectively. At the same condition, the IC~50~ value of staurosporine against K562 leukemia cells was 16.7 nM.

![Key HMBC and NOESY of **2**.](molecules-19-21378-g003){#molecules-19-21378-f003}
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###### 

IC~50~ values of compounds **1**--**7** against colorectal cancer CT26 and leukemia K562 cells.

  Compounds   IC~50~ (μM)   
  ----------- ------------- ------
  **1**       \>20          \>20
  **2**       \>20          \>20
  **3**       \>20          \>20
  **4**       15.3          19.9
  **5**       18.2          12.5
  **6**       6.7           \>20
  **7**       8.4           23.1

The IC~50~ value of staurosporine, the positive control, against K562 cells was 16.7 nM.

3. Experimental
===============

3.1. General
------------

Optical rotations were measured on a JASCO DIP-1000 polarimeter (Tokyo, Japan). ^1^H and ^13^C-NMR were acquired on a Bruker DMX-500 (Ettlingen, Germany). Low resolution and high resolution mass spectra were obtained using an API4000 triple quadrupole mass spectrometer (Applied Biosystems, Foster City, CA, USA) and a Synapt High Definition Mass Spectrometry system with an ESI interface and a TOF analyzer (Waters Corp., Manchester, UK), respectively. IR spectra were recorded on a JASCO FT/IR 4100 spectrometer (Tokyo, Japan). TLC was performed using silica gel 60 F~254~ plates (200 µm, Merck, Taipei, Taiwan).

3.2. Fungal Material
--------------------

Freeze-dried powder of *Antrodia camphorata* was provided by Kang Jian Biotech Corp. Ltd, Nantan, Taiwan R.O.C.

3.3. Extraction and Isolation
-----------------------------

The dried powder (2.83 kg) of solid-state cultured *Antrodia camphorata* was extracted with 12 L methanol for three times, and the concentrated residues (323.8 g) were suspended in H~2~O and further partitioned three times with equal volumes of ethyl acetate, then concentrated in vacuum to dryness (131.5 g). The ethyl acetate extract was applied onto an open column with silica gel. The column was eluted with mixtures of *n*-hexane, ethyl acetate and methanol, and each 1 L was collected as one fraction. Fractions 16--33 were combined and evaporated to dryness (1.4 g), which were further purified by HPLC on a semi-preparative Phenomenex Luna Si column (5 µm, 10 × 250 mm) with *n*-hexane--ethyl acetate (90:10, *v*/*v*) as the eluent, 2 mL/min, obtaining **1** (4.6 mg), **2** (6.4 mg) and **3** (8.9 mg). Fractions 92--124 were combined and evaporated to dryness (33.1 g), which were further purified by HPLC on the same column with *n*-hexane--ethyl acetate (50:50, *v*/*v*) as the eluent, 2 mL/min, obtaining **4** (5.6 mg), **5** (7.4 mg), **6** (10.3) and **7** (9.2 mg).

*6-Methoxy-4-methyl-2,3-(methylenedioxy)phenol* (**1**): Colorless amorphous solid; IR (neat): ν~max~ 3277, 3015, 1626, 1527, 1440, 1341, 1208, 1129, 1043, 925 cm^−1^. ^1^H-NMR (CDCl~3~, 400 MHz): δ~H~ 2.16 (3H, s, H-7), 3.82 (3H, s, OMe-6), 5.91 (2H, s, H-8), 6.27 (1H, s, H-6). ^13^C-NMR (CDCl~3~, 100 MHz): δ~C~ 15.8 (C-7), 57.2 (Ome-6), 101.5 (C-8), 109.0 (C-5), 118.9 (C-4), 131.9 (C-3), 133.6 (C-1), 135.0 (C-2), 136.8 (C-6). ESIMS: *m*/*z* = 183 \[M+H\]^+^. HRESIMS: *m*/*z* = 183.0653 \[M+H\]^+^ (calcd. for C~9~H~11~O~4~, 183.0657).

*4,4\'-(Ethane-1,2-diyl)bis(2,3,6-trimethoxyphenol)* (**2**): Colorless amorphous solid; IR (neat): ν~max~ 3410, 3012, 2956, 2860, 1610, 1503, 1420, 1325, 1248, 1198, 1125, 1076, 970, 880. ^1^H-NMR (CDCl~3~, 400 MHz): δ~H~ 2.78 (4H, s, H-7, -7\'), 3.79 (6H, s, OMe-3, -3\'), 3.80 (6H, s, OMe-6, -6\'), 3.91 (6H, s, OMe-2, -2\'), 5.45 (2H, brs, OH-1, -1\'), 6.38 (2H, s, H-5, -5\'). ^13^C-NMR (CDCl~3~, 100 MHz): δ~C~ 31.4 (C-7, -7\'), 56.4 (OMe-3, -3\'), 60.7 (OMe-6, -6\'), 61.0 (OMe-2, -2\'), 107.2 (C-5, -5\'), 125.2 (C-4, -4\'), 137.3 (C-1, -1\'), 140.4 (C-2, -2\'), 143.2 (C-6, -6\'), 145.2 (C-3, -3\'). ESIMS: *m*/*z* = 395 \[M+H\]^+^. HRESIMS: *m*/*z* = 395.1710 \[M+H\]^+^ (calcd. for C~20~H~27~O~8~, 395.1706).

3.4. Cells and Viability Assay
------------------------------

Murine colorectal cancer CT26 cells were cultured in RPMI1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Hyclone, Logan, UT) and 2 mM [l]{.smallcaps}-glutamine at 37 °C in a humidified 5% CO~2~ incubator. The viability of CT26 cells was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma) colorimetric assay. Human chronic myeloid leukemia K562 cells were cultured in RPMI 1640 medium, 10% FBS and 2 mM [l]{.smallcaps}-glutamine at 37 °C in an incubator. The viability of K562 cells with compound treatments for one day were measured using the Trypan blue dye exclusion test. The IC~50~ values of compounds in CT26 and K562 cells were determined by using SigmaStat software (Jandel Scientific, San Rafael, CA, USA).

4. Conclusions
==============

In this study, three C~6~-C~1~ derivatives, as well as four phytosteroids with rearranged skeletons were isolated from the industrial fermented products of *Antrodia camphorata*. Of the compounds isolated, four phytosteroids exhibited significant cytotoxicity against cancer cell lines, which may, to some extent, account for the traditional uses of this fungal product as a health food to treat cancer. More experiments should be performed to deduce the action modes of these compounds.
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